Kepos Capital’s Ibere Pharmaceuticals Units IBER.U Stock Holding History
Bought
Maintained
Sold
Other funds holding IBER.U
CCA
Kepos Capital's IBER.U Position: Q2 2021 in Review
Kepos Capital sold out of Ibere Pharmaceuticals Units (IBER.U) in Q2 2021, closing a stake of 495,400 shares — an estimated $4.88M sold.
Kepos Capital first reported a position in IBER.U in Q1 2021 and held it in 1 quarter. The position peaked at $4.88M in Q1 2021. 34 funds tracked by Wall St. Rank hold IBER.U as of Q2 2021.
- Kepos Capital reported no remaining Ibere Pharmaceuticals Units position as of Q2 2021 after selling out during the quarter.
- Kepos Capital sold 495,400 Ibere Pharmaceuticals Units shares in Q2 2021, an estimated $4.88M.
- Kepos Capital first reported a position in Ibere Pharmaceuticals Units in Q1 2021 and held it in 1 quarter.
- Kepos Capital's Ibere Pharmaceuticals Units position peaked at $4.88M in Q1 2021.
- 34 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units as of Q2 2021.
Based on Kepos Capital's 13F filing for Q2 2021, filed 12 Aug 2021.